A WHO consultation identified the most vulnerable groups as elderly individuals, infants, preschool-aged children, and pregnant or lactating women, due to either increased nutritional demands or impaired absorption capacity (de Benoist, 2008)
(PubMed) Ashor AW, Werner AD, Lara J, Willis ND, Mathers JC, Siervo M
No serious adverse events have been systematically documented in human use to date, though the absence of systematic reporting infrastructure in the research peptide space means that adverse events are almost certainly underreported
Sourced and produced through a controlled US supply chain
Medical oversight cannot remove every uncertainty, but it can reduce the risk of decisions based only on online claims or product availability